Response of serum C-reactive protein to percutaneous coronary intervention has prognostic value

Clinical Chemistry

Volumn 51, Issue 11, 2005, Pages 2124-2130

  Saleh, Nawsad ^a   Svane, Bertil ^a   Hansson, Lars Olof ^b   Jensen, Jens ^a   Nilsson, Tage ^a   Danielsson, Olle ^a   Tornvall, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TROPONIN T;

ADULT; AGED; ARTICLE; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE INJURY; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ANGINA PECTORIS; ANGIOPLASTY, BALLOON; C-REACTIVE PROTEIN; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT;

EID: 27444445366     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.048082     Document Type: Article

References (26)

1. Buffon A, Liuzzo G, Biasucci L, Pasqualetti P, Ramazzotti V, Rebuzzi AG, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999;34:1512-21.
2. Chew D, Bhatt D, Robbins M, Penn MS, Schneider JP, Laner MS, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001;104:992-7.
3. Heeschen C, Hamm CW, Bruemmer J, Simoons ML. The chimeric c7E3 antiplatelet therapy in unstable angina refractory to standard treatment (CAPTURE) investigators. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. J Am Coll Cardiol 2000;35:1535-42.
4. Rahel B, Visseren F, Suttorp M, Plokker TH, Kelder JC, de Jongh BM, et al. Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention. Cardiovasc Res 2003;60:136-40.
5. Walter D, Rchtlscherer S, Britten M, Rosin P, Auch-Schwelk W, Schachniger V, et al. Statin therapy, inflammation, and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol 2001;38:2006-12.
6. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA, et al. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 2000;85:92-5.
7. Winter R, Koch K, Van Straalen J, Heyde G, Bax M, Schotborgh CE, et al. C-Reactive protein and coronary events following percutaneous coronary angioplasty. Am J Med 2003;115:85-90.
8. Winter R, Heyde G, Koch K, Fischer J, Van Straalen J, Bax M, et al. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J 2002;23:960-6.
9. Lenderink T, Boersma E, Heeschen C, Vaharian A, de Boer MJ, Umans V, et al. Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PCI. Eur Heart J 2003;24:77-85.
10. Zairis M, Ambrose J, Manousakis S, Stefanidis AS, Papadaki OA, Bilianou HI, et al. The impact of plasma levels of C-reactive protein, lipoprotein(a), and homocysteine on the long-term prognosis after successful coronary stenting. The global evaluation of new events and restenosis after stent implantation study. J Am Coll Cardiol 2002;40:1375-82.
11. Dibra A, Mehilli J, Braun S, Hadamitzky M, Baum H, Dirschinger J, et al. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 2003;114:715-22.
12. Azar R, McKay R, Kiernan F, Seecharran B, Feng Y, Fram D, et al. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 1997;80:1476-8.
13. Liu PY, Li YH, Tsai WC, Chao TH, Tsai LM, Wu HL, et al. Prognostic value and the changes of plasma levels of secretory type II phospholipidase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention. Eur Heart J 2003;24:1824-32.
14. Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiariello L, et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 1998;82:515-8.
15. Davis G. Role of cardiac troponin testing in percutaneous transluminal coronary angioplasty. Scand J Clin Invest 2003;63:167-74.
16. Braunwald E. Unstable angina: a classification. Circulation 1989;80:410-4.
17. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. The fragmin during instability in coronary artery disease (FRISC) study group. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000;343:1139-47.
18. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. C-Reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI-11A) substudy. J Am Coll Cardiol 1998;31:1460-5.
19. Carims JA, Theroux P, Lewis HD, Ezekowitz M, Meade TW. Antithrombotic agents in coronary artery disease. Chest 2001;119(1 Suppl):228S-52S.
20. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
21. Ikonomidis I, Adreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulus P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999;100:793-8.
22. Feng D, Tracy RP, Lipinska I, Murillo J, McKenna C, Toiler GH. Effect of short-term aspirin use on C-reactive protein. J Thromb Thrombolysis 2000;9:37-41.
23. Feldman M, Jilal I, Devaraj S, Cryer B. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations. A placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol 2001;37:2036-41.
24. Albert M, Danielson E, Rifai N, Ridker PM; PRINCE Investigators. Effect of statin therapy on C-reactive protein levels. JAMA 2001;286:64-70.
25. Chan A, Bhatt D, Chew D, Quinn MJ, Molterno DJ, Topol EJ, et al. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation 2002;105:691-6.
26. Vivekananthan D, Bhatt D, Chew D, Zidar FJ, Chan AW, Molterno DJ, et al. Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention. Am J Cardiol 2004;94:358-60.